Pelvic Lymph Node Dissection During Radical Prostatectomy
Seeking advice regarding bilateral pelvic lymph node dissection (ePLND) for Gleason 3+4=7 (Grade Group 2) prostate cancer.
My upcoming RALP with Dr. Dechet at the Huntsman Cancer Institute includes a bilateral pelvic lymph node dissection. However, when I discussed this with my local urologist, he dismissed the necessity of the node dissection, suggesting it is often performed at teaching hospitals primarily for training purposes rather than clinical necessity.
Given my favorable intermediate risk status (no cribriform pattern), I am trying to reconcile these conflicting perspectives. I recently came across new research (see link below) suggesting that pelvic node removal is increasingly recommended for patients in my risk category. This paper is particularly significant because its primary endpoint was the reduction in the risk of distant metastasis, rather than solely focusing on biochemical recurrence.
My local urologist has questioned why I am not choosing a local procedure, but I find the expertise of a high-volume RALP surgeon like Dr. Dechet to be far more compelling. I’ve decided that the travel required for a specialist is negligible. I would appreciate hearing if others have navigated this kind of disagreement between local surgeons and specialists regarding the necessity of lymph node dissection.
Has anyone else faced a similar discrepancy between a surgeon at a major cancer center and a local urologist/surgeon regarding the necessity of lymph node dissection?
https://www.auajournals.org/doi/full/10.1097/JU.0000000000004821